Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. Blood. 2011 Sep 29; 118(13):3525-7.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow Neoplasms
Cohort Studies
Cyclophosphamide
Female
Follow-Up Studies
Humans
Incidence
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Neoplasms, Second Primary
Time Factors
United States
Vidarabine

authors with profiles

Richard A. Larson